...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

"Can you see any possible strategic possibilities as to why more in depth details have not been released?"

I'mĀ assuming that you are talking about BETonMACE2 design details. They are still in the planning stages and things are likely in flux. Concrete details will be disclosed closer to trial initiation. Very likely many facets are still undecided.

BDAZ

As we all hope, maybe there are more than one Pharma in partnering discussions and whichever is successful will have their input on trial design. I would think it is pretty hard to give too many details before there is a partnership deal so those can be finalized.

Share
New Message
Please login to post a reply